Screen time and pulmonary function in hospitalized children with cystic fibrosis

Vanessa Dos Santos Rodrigues1, Caroline Schmidt2, Gleice Kelly Medeiros1

  • 1. Programa de Saúde da Criança, Hospital de Clínicas de Porto Alegre - HCPA - Universidade Federal do Rio Grande do Sul - UFRGS - Porto Alegre (RS) Brasil.

Insights

Excessive screen time (ST) is linked to poorer lung function in hospitalized children with cystic fibrosis (CF). Older age and more TV time at home also correlated with worse outcomes.

Area of Science:

  • Pediatric Pulmonology
  • Cystic Fibrosis Research
  • Digital Health Impact

Background:

  • Cystic Fibrosis (CF) requires ongoing management, including monitoring lung function.
  • Hospitalization in CF patients often involves limited activities, potentially increasing screen time.
  • The impact of screen time on health outcomes in pediatric CF populations is not well-established.

Purpose of the Study:

  • To investigate the association between screen time (ST) and lung function in hospitalized children and adolescents with CF.
  • To identify factors associated with screen time during hospitalization for CF.

Main Methods:

  • Cross-sectional study involving 45 pediatric CF patients (0-17 years) hospitalized in Brazil.
  • Screen time assessed via recall diary; additional data collected through questionnaires and medical records.
  • Lung function (FEV1 Z-score), nutrition, bacteriology, and clinical scores were analyzed.

Main Results:

  • The majority of participants (95.5%) exceeded recommended screen time limits.
  • Median screen time was 315 minutes, primarily due to boredom and lack of activities.
  • Multivariate analysis revealed significant associations between screen time, age, home TV viewing, and FEV1 Z-score.

Conclusions:

  • Elevated screen time is associated with diminished lung function in hospitalized CF children.
  • Older age and greater time spent watching television at home are also linked to poorer lung function outcomes.
  • Findings suggest a need to consider screen time management in pediatric CF care during hospitalization.
Abstract

Related Concept Videos

Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Pulmonary Function Tests01:25

Pulmonary Function Tests

Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...